A.R.T. Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-29,813
| Closed | -$1.13M | – | 1777 |
|
|
2018
Q3 | $1.13M | Sell |
29,813
-27,500
| -48% | -$1.04M | 0.05% | 530 |
|
|
2018
Q2 | $2.59M | Buy |
57,313
+21,100
| +58% | +$954K | 0.11% | 277 |
|
|
2018
Q1 | $1.75M | Buy |
36,213
+27,400
| +311% | +$1.32M | 0.07% | 443 |
|
|
2017
Q4 | $346K | Sell |
8,813
-82,000
| -90% | -$3.22M | 0.02% | 1021 |
|
|
2017
Q3 | $2.82M | Sell |
90,813
-9,000
| -9% | -$279K | 0.14% | 183 |
|
|
2017
Q2 | $2.73M | Buy |
99,813
+83,800
| +523% | +$2.29M | 0.14% | 177 |
|
|
2017
Q1 | $590K | Buy |
+16,013
| New | +$590K | 0.03% | 754 |
|
|
2016
Q3 | – | Sell |
-63,180
| Closed | -$1.05M | – | 1288 |
|
|
2016
Q2 | $1.05M | Buy |
63,180
+6,780
| +12% | +$112K | 0.05% | 528 |
|
|
2016
Q1 | $894K | Buy |
56,400
+41,600
| +281% | +$659K | 0.04% | 631 |
|
|
2015
Q4 | $478K | Buy |
+14,800
| New | +$478K | 0.02% | 883 |
|